Action | Promulgate regulation regarding industrial hemp extracts intended for human consumption as required by Ch. 659 and 660 of the 2020 Acts of Assembly |
Stage | Proposed |
Comment Period | Ended on 1/7/2022 |
For the proposed 2VAC5-595-60.D, the information on how a manufacturer determines concentration of cannabinoids should be made publicly available, to the consumers. In addition, there should be a laboratory verification requirement. Alcohol manufacturers are required to list and test ABV, cannabis manufacturers should be required to do the same for cannabinoids for consumer safety and transparency.